What is Nemera?

Nemera is a world leader in the design, development and manufacturing of drug administration devices for the pharmaceutical, biotechnology and generics industries.

What does Nemera do?

Nemera provided the most comprehensive range of devices in the industry, including off-the-shelf innovative systems, customized design development and GMP manufacturing of devices developed by our customers. Nemera’s products cover a range of delivery routes including Ophthalmic, Nasal, Inhalation, Parenteral, Dermal and Transdermal.

The opportunity:

  • Leading provider of complex drug administration systems with #1 global positions in several niches (e.g. respiratory, dermal)
  • Supplies products used on a daily basis by millions of patients suffering from chronic diseases globally (e.g. insulin pens)
  • Sustained market growth of 6-8% p.a. driven by increased disease prevalence (e.g. diabetes), new drug launches and stricter patent compliance
  • Entrenched leadership protected by long-term relationships with customers, extensive pharma-grade manufacturing experience (GMP, clean rooms), and multi-year contracts

Why we like the investment

Opportunity to acquire a corporate orphan with a solid market position in a growing market, led by a management team well known to Montagu. Nemera is a leading provider of complex drug administration systems with #1 global positions in several niches (e.g. respiratory, dermal).

Investment year

2014

Head office

France

Status

Invested

Website

https://www.nemera.net/

Risk warning
Risk warning
The value of investments and the income from them can go down as well as up and you may get back less than the amount invested. The tax benefits relating to ISA investments may not be maintained. Investors should review the relevant Key Information Document (KID) brochure prior to making an investment decision.
Read the detailed risk warning 
Investor warning: Please be aware of scams that can affect investors. Read the full investor risk warning